Programs Launched to Provide Health and Pharma Services to Underserved Patients
Hoy Health, LLC has unveiled healthcare and pharmaceutical programs designed specifically for medically underserved patients. According to Hoy, timing of the launch of the cash-based wellness programs comes on the heels of Hispanic Heritage Month, which ran from September 15 through October 15. An emerging health-tech company, Hoy Health offers affordable Rx drugs, chronic condition management programs, and telehealth/virtual care. …
FDA Drug Shortages and Discontinuations: 10/22/18 Update
Report: Teva Suffers Migraine Over Express Scripts Drug Exclusion
Catalent and Verastem Partner on Newly Launched Cancer Treatment
FDA Drug Shortages and Discontinuations: 10/15/18 Update
Lonza Expands HPAPI Capacity for Antibody Drug Conjugate Payloads
FDA Drug Shortages and Discontinuations: 10/3/18 Update
FDA Drug Shortages and Discontinuations: 9/25/18 Update
FDA Drug Shortages and Discontinuations: 9/17/18 Update
The FDA has issued recent updates on several drugs that are currently in shortage or have been discontinued: Asparaginase Erwinia Chrysanthemi (Erwinaze) (Updated – Currently in Shortage) Bumetanide Injection, USP (Updated – Currently in Shortage) Daclatasvir Tablets (New – Discontinuation) Darifenacin Hydrobromide Tablets (New – Discontinuation) Dobutamine Hydrochloride Injection (Updated – Currently in Shortage) Epinephrine Injection, Auto-Injector (Updated – Currently in Shortage) Etoposide Injection (Updated –…